News Releases

Einstein Researchers Awarded $3.5 Million NIH Grant to Study Brain Changes Caused by COVID-19
Research Reveals Secrets of Baffling but All-Too-Common Type of Diabetes
Einstein Celebrates 64th Commencement

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

Jan Vijg

Jan Vijg, Ph.D.

Area(s) of expertise: GeneticsGenomic instabilityAging

Dr. Vijg studies the molecular genetic changes associated with aging. Instability of genome and epigenome – the entire set of an organism’s genes and the switches that control their activity –  has long been implicated… Learn more

Einstein in the News

Academic Minute
Rare Disease: When The Diagnoses Is Not The Answer

Steven Walkley, D.V.M., Ph.D., describes "gene teams" at Einstein and Montefiore in which physicians and scientists provide clinical information and research updates to parents of children diagnosed with rare genetic diseases. Dr. Walkley is co-director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center and professor in the Dominick P. Purpura Department of Neuroscience, of pathology, and in the Saul R. Korey Department of Neurology. 

More coverage on Dr. Walkley

COVID Convalescent Plasma Finds a Therapeutic Role

Liise-anne Pirofski, M.D., co-authored a commentary on the benefits of convalescent plasma for treating immunocompromised patients who have COVID-19. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore, professor of medicine and of microbiology & immunology, and holds the Selma and Dr. Jacques Mitrani Chair in Biomedical Research at Einstein.

More coverage on Dr. Pirofski

The Scientist
Diabetes Linked to Malnutrition is Metabolically Unique: Study

Meredith Hawkins, M.D., M.S., explains her study that describes a metabolically distinct type of diabetes characterized by low body weight and problems with insulin secretion—a crucial step toward developing effective treatments. Dr. Hawkins is the founding director of the Global Diabetes Institute, professor of medicine, and the Harold and Muriel Block Chair in Medicine at Einstein.

Additional coverage includes UPI and The Hindu

More coverage on Dr. Hawkins


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog